What type of study is this?

Prevalence of 3,4-Methylenedioxy-α-Pyrrolidinohexanophenone (3,4-MDPHP) in 465 Suspected Intoxication Cases and Cross-Reactivity Evaluation in an Ecstasy Immunoassay

View Full Paper

Ask AI

Bookmark

Authors

Analysis shows 3,4-MDPHP prevalence at 56% in intoxications, suggesting cross-reactivity with immunoassay in 26.9% cases.

Intoxication cases detected 3,4-MDPHP in 56% of subjects, indicating a serious health concern.
Out of 465 suspected intoxications, 108 tested positive for 3,4-MDPHP using GC-MS and LC-MS/MS methodologies.
Cross-reactivity evaluation found 3,4-MDPHP metabolites may trigger positive ecstasy immunoassay results.
Awareness of diagnostic errors linked to 3,4-MDPHP cross-reactivity in clinical laboratories is crucial.

Pasi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark